15mg His蛋白/mL基质,洗脱温和可重复使用,多规格可询,2-8℃保存有效期4年。" data-qmeta="description">

3522集团新网站

分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Chitopentaose inhibits hepatocellular carcinoma by inducing mitochondrial mediated apoptosis and suppressing protective autophagy

Zhu Chunfeng, Zhao Mengyao, Fan Liqiang, Cao Xuni, Xia Quanming, Zhou Jiachun, Yin Hao, Zhao Liming

Journal:Bioresources and Bioprocessing

IF:4.58

DOI:10.1186/s40643-020-00358-y

PMID:

Published:2021-01-05

research field:代谢免疫学肿瘤免疫学分子肿瘤学T细胞生物学信号转导神经肿瘤学

Abstract

Hepatocellular carcinoma (HCC) is one of the most prevalent and deadliest cancers. In this study, the anti-tumor effect of singular degree of polymerization (DP) chitooligosaccharides (COS) (DP 2–5) and the underlay molecular mechanisms were investigated on HCC cell line HepG2. MTT assay showed that (GlcN) 5 have the best anti-proliferation effect among the different DP of COS (DP2-5). Furthermore, the administration of (GlcN) 5 could decrease mitochondrial membrane potential, release cytochrome c into cytoplasm, activate the cleavage of Caspases9/3, thus inducing mitochondrial-mediated apoptosis in HepG2 cells (accounting for 24.57 ± 2.25%). In addition, (GlcN) 5 treatment could increase the accumulation of autophagosomes. Further investigation showed that (GlcN) 5 suppressed protective autophagy at the fusion of autophagosomes and lysosomes. Moreover, the inhibition of protective autophagy flux by (GlcN) 5 could further decrease cell viability and increase the apoptosis rate. Our findings suggested that (GlcN) 5 suppressed HepG2 proliferation through inducing apoptosis via the intrinsic pathway and impairing cell-protective autophagy. COS might have the potential to be an agent for lowering the risk of HCC.

本文使用的Yeasen产品

购物车
客服
转染试用